Experiments in a mouse model of AD showed that the activation of α7 nicotinic receptors leads to downregulation of glycogen synthase kinase-3 (GSK3), a kinase involved in Aβ oligomer-induced inhibition of LTP as well as tau hyperphosphorylation [283, 284]. This evidence concerns the gene MAPT and Alzheimer disease.